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ABSTRACT 
To observe the changed in periodontal disease in asthma patients using corticosteroid drugs. Electronic searches on Wiley, Pubmed, and Cochrane 
were conducted to identify articles published in dental journals from January 2004 to December 2017 focusing on the effects of corticosteroid use in 
asthma patients. Manual searches of published full-text articles and related articles were performed afterwards. Of the 73 studies that explain this, 
only 3 studies were compatible with the inclusion criteria. The initial database search produced 195 articles. All articles were selected for full-text 
review. There were 3 studies selected for inclusion, with 97.837 patients as subjects. Most studies were using inhaled corticosteroids in addition to 
the use of systemic corticosteroid drugs, and antihistamines. One studies mention that there no evidence of association been asthma and 
periodontal disease from the adolescent population. Corticosteroids are used in the treatment of asthma diseases, but the use of corticosteroid 
drugs, especially with inhaled methods, increases the risk of periodontal disease compared to patients who do not use corticosteroid drugs. 
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Asthma is a respiratory disease with characteristics of inflammation 
and bronchoconstriction, which can occur in any age group, such as 
children, adolescents, adults, and elderly [1]. Infection in the 
respiratory tract, allergies, exposure to allergens, and weather 
changes are the trigger factors in asthma with different symptoms 
and limited respiratory tract. This condition can limit the activity 
and the acute condition can cause the main problem in health care 
and in some cases, the condition can become fatal and cause death 
[2]. The prevalence of asthma is about 300 million people in the 
world and this number is assured to increase by 100 million people 
in 2025 [3]. Therefore, the pharmacological choices to treat asthma 
disease are by reducing the disease symptom, controlling the 
disease, and providing additional therapy [2]. 
In adults, the prevalence of asthma disease is higher in women than 
men. Recently, the more effective and available treatment for asthma 
is by using inflammatory medication (e. g. inhaled glucocorticosteroid) 
and also can by adding bronchodilator agent (e. g. agonist β2) if 
necessary [4]. Patients who are using an inhaler must be given a clear 
instruction of use: 4 times daily. A long-term of the drug’s usage can 
cause a health problem in the oral cavity [3]. McDerra et al. [5]. Found 
that 4–10 y old children with asthma disease usually have more plaque 
and calculus than healthy children without asthma. They also have a 
higher prevalence of gingivitis. In 1992, Von Wowern et al. [6]. Also 
reported that the reduced composition bone mineral of the mandible 
may be caused by the used of systemic corticosteroid. 
MATERIALS AND METHODS 
This systematic review was written based on the PRISMA guidelines 
(Preferred Reporting Items for Systematic Reviews and Meta-
Analyses) for reporting the events evaluated by interventions and 
health care behaviors [7]. PICO questions (population, intervention, 
control, and outcome) [8] used in this systematic review were:  
P (population): children, adults, and elderly patients who are 
suffering from asthma 
I (intervention): the use of anti-asthmatic drugs corticosteroid and 
antihistamines 
C (comparison/control): healthy patients without asthma 
O (outcome): the relation between periodontal disease and asthma 
patients who were using anti-asthmatic drugs such as corticosteroid 
Search strategy 
The electronic searches were conducted on Wiley Online Library, 
PubMed, and Cochrane Online Library databases focusing on English 
literature, which supports this study. The searches were done to 
identify published articles in the dental journal from January 2004 to 
December 2017, focusing on the use of the anti-asthmatic drug’s 
effects on periodontal disease in asthma patients. The MesH 
keywords used in this search were “asthma” and “corticosteroid”. 
The searches were limited to English articles, publication date, and 
type of articles. The manual searches of the full-text articles were 
done afterward. There were 73 studies compatible with this, but 
only 3 studies were compatible with the inclusion criteria. The drugs 
used in this study were anti-asthmatic drugs (e. g. corticosteroid) 
and antihistamines. 
The specific keywords were used in this search and the results were 
evaluated based on PICO questions characteristics. 
Eligibility criteria 
The inclusion criteria in this systematic review are based on 
parameters which are the articles that published in English from 
January 2004 to December 2017 about periodontal disease associated 
with corticosteroid in asthma patients and at least 24-30 mo after 
using follow up evaluation. The age of patients was about 7-86 y old.  
While the exclusion criteria used in this systematic review are the 
article that published in not in English, articles in any systematic 
review and meta-analyses, the articles only explaining other 
respiratory diseases. 
Selection of study 
The specific keywords were used by participating authors to find the 
articles by reviewing and selecting the abstract and full-text articles. 
The authors then selected the articles that were compatible with the 
inclusion criteria independently. After that, all the abstract and full-
text articles were downloaded and evaluated individually. The 
eligibility criteria was used to identify the articles which will be used 
in this systematic review. 
Data extraction 
The data were extracted by the authors with the following 
parameter: publication year, studies on the animal, and other 
accompanying diseases. All the full-text articles that were 
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compatible with the inclusion criteria were reviewed independently 
by reviewers and evaluated to conclude this systematic review. 
RESULTS 
The search on the database resulting in 195 initial articles (190 
articles from Wiley Online Library, 4 articles from PubMed database, 
and 1 article from Cochrane Online Library). Because of the 
irrelevant titles, 73 articles were excluded. After the discussion 
between the authors, another 70 articles were excluded because of 
several reasons. The title and the abstract of the articles were 
reviewed again and as the results, only 3 studies were qualified to be 
analyzed. The diagram flow of the articles selection was shown in fig. 
1 with a total of 3 articles chosen from 195 initial articles. After 195 
articles were reviewed, 3 articles were selected to be included in this 
systematic review, while another 192 articles were excluded 
because of several reasons. 
All the studies were done in the last 15 y in the United States (1), 
India (1) and Taiwan (1). There were 97 837 patients in these 
studies, with 19 549 subjects were suffering from asthma and 78 
288 patients were healthy individuals. Most of the patients were 
from the study conducted in Taiwan, which is 96 030. All the studies 
were using agonist corticosteroid β2 to treat asthma. 
  
 
Fig. 1: The diagram flow of the articles selection 
 
Table 1: Data description from the 3 included studies that were reported on anti-asthmatic drugs 
Authors 
(y) 








asthma dan 1358 non-
asthma) 




• Anti-asthmatic inhaler for 
24 mo 
• Anti-histamine for 30 mo 
• Corticosteroid not reported 
 
None of the periodontal measures are 
associated with severe asthma or with 
the use anti-asthmatic drugs but some 




211 children, (105 
asthma patients, 106 
healthy control) 
Age 6-14 y 
India  Case-control 
PIS  
• Agonist Beclomethasone 
inhaler 
• Salbutamol inhaler 
• Salbutamol tablet 
• each one-year usage 
There was a significant value of P<0.05 
Shen et al. 
(2017)[2] 
Adult participants 
(96,030) with 19, 206 
asthma and  
76, 824 non-asthma 




PIS and GI 
• Systemic corticosteroids 
ICS+long-acting  
• Theophylline  
• Montelukast 
• Omalizumab 
• Each one-year usage 
All periodontal parameters were 
assessed and the results were 




GB: Gingival Bleeding 
CAL: Clinical Attachment Level 
PD: Probing Depth 
CI: Calculus Indeks 
PIS: Periodontal Indeks 
GI: Gingival Indeks 
Table 1 showed two case-control studies and one cohort 
retrospective study. The studies were conducted in 2003, 2007, and 
2017. The patients’ age mean was 41.5 y old. In the 13–17 y old 
group, the participant numbers were 1.596 people, while in the 6–14 
y old group, the participant numbers were 211 people. Sashikiran et 
al. [10] observed their asthma patients who were using inhaled 
corticosteroid β2, salbutamol inhaler, and salbutamol tablet in 
treating asthma. In the USA, Shulman et al. [9] and in Taiwan, Shen et 
al. [2] also observed the same condition where their asthma patients 
also used anti-asthmatic drugs in their treatment. 
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DISCUSSION 
In this study, there was a significant difference in the inflammation 
of the gingiva between asthma patients and healthy individuals, 
especially the one who were using inhaled corticosteroid. The 
corticosteroid immunosuppressive effect may influence the 
response of the periodontal tissue. These agents inhibit the host 
response, thus resulting in the clinical expression of gingivitis [11]. 
The two included studies also reported about a positive association 
between medications for asthma and periodontal diseases. However, 
one study showed a negative relation between asthma and 
periodontal diseases. None of the periodontal measures are 
associated with severe asthma or with the use of anti-asthmatic 
drugs. The last study observed that subjects were taking 
medications and were less subject show gingival changes. The first 
reason is that the subjects were using a low dose for less time 
comparing to the others study. The second one is the subject were 
not paying attention in the clinical procedure or not using the drugs 
as directed. The last reason is maybe the effect of the anti-asthmatic 
drugs were different between adult’s patients and children patients 
because the hormonal changes effect in adults is associated with 
puberty.  
Periodontal diseases are body reaction caused by plaque bacteria on 
the tooth crown which then extends into the gingival sulcus and 
impair the adjacent gingiva such as chronic inflammation, gingival 
bleeding, pocket depth increased, and loss of alveolar bone. Most 
common bacteria found in people suffering from periodontal disease 
are porphyromonas gingivalis, Treponema denticola, tannerella 
forsythia and A. actinomycetemcomitans. The bacterial antigen will 
trigger the host immune response, and resulting in the effect of the 
disease. In the diseases like asthma, the immune response is a 
mechanism which involved in the pathogenesis and the disease 
progression. Even though most of the patients of this disease are 
adults, there was a significant portion shown in the children and 
adolescence group [9, 12]. 
Hyppa et al. [13] reported that gingivitis in children who were 
suffering from asthma was explainable. Some immune response 
changes and they usually breathe from the mouth (mouth 
breathing), especially while the episodes of acute asthma attacks and 
dehydration of the alveolar mucosa. Karl et al. [14] reported that the 
prevalence of periodontal disease and saliva flow were lower in 
asthma patients than non-asthma patients. The higher prevalence of 
calculus in children with asthma is caused by the increasing calcium 
and phosphorus level in saliva excreted by the submaxillary and 
parotid gland. Wotman et al. [15] reported that children with asthma 
have more calculus than healthy children. Lenander et al. [16] 
reported that even the flow of saliva was reduced, myeloperoxidase 
concentration was increased in asthma patients. IgE concentration 
in gingival tissue was increased in asthma patients which cause 
periodontal destruction. 
Even though the published studies had reviewed about asthma 
patients with different ethnic and social-economic population with 
different severity of the disease and the types and doses of the drugs, 
the study in asthma patients who were using inhaled corticosteroid 
must providing information and proper guidance, because if it is not 
well controlled, this will cause inflammation of the gingiva and 
caries because of the reduced flow of saliva [17]. Especially in 
children patients who were using their drugs at night, before sleep, 
and without cleaning or rinsing their mouth after usage [11]. 
CONCLUSION 
Anti-asthmatic drugs such as corticosteroid and anti-histamine were 
usually used in asthma disease treatment, but the use of 
corticosteroid drugs especially with inhaled methods increased the 
risk of periodontal diseases like gingivitis and severe periodontitis 
than the one who does not use corticosteroid drugs. All the asthma 
patients who were using anti-asthmatic drugs should check their 
oral health periodically. Further study is required to produce more 
specific information with more samples and better methodology. 
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